Financial statements Bioalt
Balance sheet of Bioalt
Company age:
Age:
10 y. 4 m. 28 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of BIOALT
|
Year
|
2019
|
2020
|
2021
|
|---|---|---|---|
| Total assets | 149 810,87 | 133 242,41 | 45 025,17 |
| A. Fixed assets | 19 568,83 | 19 568,83 | 0,00 |
| B. Current assets | 130 242,04 | 113 673,58 | 45 025,17 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 149 810,87 | 133 242,41 | 45 025,17 |
| A. Equity | 126 440,87 | 132 856,27 | 32 725,17 |
| B. Liabilities and provisions for liabilities | 23 370,00 | 386,14 | 12 300,00 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | 23 370,00 | 386,14 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.